DEXTROSE 5% AND POTASSIUM CHLORIDE 0.075% Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Dextrose 5% And Potassium Chloride 0.075%, and when can generic versions of Dextrose 5% And Potassium Chloride 0.075% launch?
Dextrose 5% And Potassium Chloride 0.075% is a drug marketed by Fresenius Kabi Usa, Baxter Hlthcare, and B Braun. and is included in three NDAs.
The generic ingredient in DEXTROSE 5% AND POTASSIUM CHLORIDE 0.075% is dextrose; potassium chloride; sodium chloride. There are nine drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the dextrose; potassium chloride; sodium chloride profile page.
Summary for DEXTROSE 5% AND POTASSIUM CHLORIDE 0.075%
US Patents: | 0 |
Applicants: | 3 |
NDAs: | 3 |
Finished Product Suppliers / Packagers: | 2 |
Formulation / Manufacturing: | see details |
DailyMed Link: | DEXTROSE 5% AND POTASSIUM CHLORIDE 0.075% at DailyMed |
Pharmacology for DEXTROSE 5% AND POTASSIUM CHLORIDE 0.075%
Drug Class | Osmotic Laxative Potassium Salt |
Mechanism of Action | Osmotic Activity |
Physiological Effect | Increased Large Intestinal Motility Inhibition Large Intestine Fluid/Electrolyte Absorption |